Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Blaise Baxter

Vascular & Interventional Radiology San Francisco, CA Medical Doctor

NPI 1487681342 CMS profile 203618

1100 Van Ness Ave, San Francisco, CA 94109

Open in the dashboard

General payments

$757,269

322 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$2,112,812

6 holdings reported · through program year 2025

Through program year 2025, Blaise Baxter of San Francisco, CA is reported in the CMS Open Payments database as having received $757,269 across 322 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $2,112,812 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $21,986 18
2024 General $59,186 54
2023 General $79,070 63
2022 General $38,291 30
2021 General $350,960 33
2020 General $91,526 24
2019 General $116,250 100
2025 Ownership $503,234 1
2024 Ownership $457,207 1
2023 Ownership $320,803 1
2022 Ownership $298,069 1
2021 Ownership $298,069 1
2020 Ownership $235,429 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Blaise Baxter
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Blaise Baxter were reported at $21,986. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Blaise Baxter Vascular & Interventional Radiology median Middle half National median
2019 $116,250 $422 $125–$1,555 $163
2020 $91,526 $200 $68–$652 $114
2021 $350,960 $280 $99–$866 $132
2022 $38,291 $433 $137–$1,497 $149
2023 $79,070 $506 $152–$2,019 $160
2024 $59,186 $556 $175–$1,930 $164
2025 $21,986 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $339,518 4 payments
  2. Penumbra, Inc. $250,871 181 payments
  3. Medical Device Business Services, Inc. $106,493 62 payments
  4. Route 92 Medical, Inc. $17,855 9 payments
  5. Stryker Corporation $12,765 31 payments
  6. Imperative Care, INc $10,197 17 payments
  7. Medtronic, Inc. $9,658 1 payment
  8. Rapid Medical LTD $8,197 1 payment
  9. Hyperfine Operations, Inc. $1,000 2 payments
  10. Inari Medical, Inc. $185 1 payment
  11. Other $529 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Acquisitions $349,151 4 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $149,550 25 payments
  3. Travel and Lodging $118,200 92 payments
  4. Consulting Fee $110,649 58 payments
  5. Food and Beverage $28,529 141 payments
  6. Education $1,000 1 payment
  7. Entertainment $189 1 payment
Products named General payments · program years 2019–2025
  1. GENERAL THERAPIES $326,224 1 payment
  2. Penumbra System Neurointervention $256,480 98 payments
  3. EMBOGUARD $57,755 27 payments
  4. Smart Coil $45,688 27 payments
  5. Penumbra System Neurointervention $24,651 24 payments
  6. Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device $16,150 9 payments
  7. General - Therapies $12,691 1 payment
  8. SURPASS EVOLVE $11,914 16 payments
  9. ZOOM 88-T LARGE DISTAL PLATFORM $9,762 11 payments
  10. Penumbra SMART Coil $9,567 7 payments
  11. Other $50,245 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 46 billing codes

Paid by Medicare

$20,215

Medicare's payments for the services billed

Medicare patients

59

Average age 74

Services billed

145

25 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Atrial fibrillation 49%
Chronic kidney disease 47%
Ischemic heart disease 42%
Heart failure 37%
Cancer 37%
Diabetes 36%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

322 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record